| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Atopic dermatitisPimecrolimusNatural productsPsoriasisRosacea| 1 | 2005 | Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. | 
| + | - | nl | BMJ 330(7490):516 (2005) Ashcroft DM |
| 2 | 2003 | Atopic dermatitis. |
| + | - | nl | South Med J 96(11):1068-72 (2003) |
| 3 | 2005 | The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation. |
| + | - | nl | Health Technol Assess 9(29):iii, xi-xiii,1-230 (2005) |
| 4 | 2000 | Systematic review of treatments for atopic eczema. | 
| + | - | nl | Health Technol Assess 4(37):1-191 (2000) |
| 5 | 2007 | Getting more and more complex: the pathophysiology of atopic eczema. |
| + | - | nl | Eur J Dermatol 17(4):267-83 (2007) |
| 6 | 2003 | Atopic dermatitis. |
| + | - | nl | Dermatol Online J 9(2):1 (2003) |
| 7 | 2009 | Evolving concepts of pathogenesis in atopic dermatitis and other eczemas. |
| + | - | nl | J Invest Dermatol 129(2):320-2 (2009) |
| 8 | 2009 | Animal models of atopic dermatitis. |
| + | - | nl | J Invest Dermatol 129(1):31-40 (2009) |
| 9 | 2009 | Atopic dermatitis: a disease caused by innate immune defects? |
| + | - | nl | J Invest Dermatol 129(1):14-30 (2009) |
| 10 | 2008 | "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. |
| + | - | nl | J Invest Dermatol 128(5):1067-70 (2008) Elias PM |
| 11 | 2004 | Consensus guidelines in diagnosis and treatment of atopic dermatitis. |
| + | - | nl | Allergy 59 Suppl 78(-):86-92 (2004) |
| 12 | 2004 | Eosinophils and atopic dermatitis. |
| + | - | nl | Allergy 59(6):561-70 (2004) |
| 13 | 2001 | Epidemiology, clinical features, and immunology of the "intrinsic" (non-IgE-mediated) type of atopic dermatitis (constitutional dermatitis). |
| + | - | nl | Allergy 56(9):841-9 (2001) |
| 14 | 2007 | Systemic treatment of severe atopic eczema: a systematic review. |
| + | - | nl | Acta Derm Venereol 87(2):100-11 (2007) |
| 15 | 2007 | The topical calcineurin inhibitor pimecrolimus in atopic dermatitis: a safety update. |
| + | - | nl | Acta Dermatovenerol Alp Panonica Adriat 16(2):58, 60-62 (2007) |
| 16 | 2011 | Hwangryunhaedoktang in adult patients with atopic dermatitis: a randomised, double-blind, placebo-controlled, two-centre trial--study protocol. |
| + | - | nl | BMC Complement Altern Med 11(-):68 (2011) |
| 17 | 2011 | Evaluation of itch by using NC/NgaTnd mice: a model of human atopic dermatitis. |
| + | - | nl | J Biomed Biotechnol 2011(-):790436 (2011) |
| 18 | 2005 | Clinical practice. Atopic dermatitis. |
| + | - | nl | N Engl J Med 352(22):2314-24 (2005) |
| 19 | 2010 | Atopic dermatitis in infants and children in India. | 
| + | - | nl | Indian J Dermatol Venereol Leprol 76(5):504-13 (2010) |
| 20 | 2005 | Pimecrolimus 1% cream for the treatment of atopic dermatitis. |
| + | - | nl | Skin Therapy Lett 10(8):1-6 (2005) |
| 21 | 2009 | Mast cells in atopic dermatitis. |
| + | - | nl | Curr Opin Immunol 21(6):666-78 (2009) |
| 22 | 2010 | Post-genomics and skin inflammation. |
| + | - | nl | Mediators Inflamm 2010(-):- (2010) |
| 23 | 2002 | Rosacea and atopic dermatitis. Two common oculocutaneous disorders. |
| + | - | nl | Can Fam Physician 48(-):721-4 (2002) |
